Human Gene Therapy

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editor-in-Chief: Guangping Gao, PhD
European Editor: Hildegard Büning, PhD
Asian Editor: Yu-Quan Wei MD, PhD
Deputy Editors: Mark Kay, MD, PhD, Thierry VandenDriessche, PhD, and Cheng Seng, PhD

ISSN: 1043-0342 | Online ISSN: 1557-7422 | Published Monthly in 12 Double Issues | Current Volume: 32

Impact Factor: 4.510 2019 Journal Citation Reports (Clarivate, 2020)

CiteScore™: 6.8

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene therapy advances.

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts Submit a Paper Share with a Colleague

News Releases

Thursday, December 10, 2020

AAV Capsid-Promoter Interactions in the Non-Human Primate Brain

Monday, November 16, 2020

NIH Gene Therapy Startup to Increase AAV Gene Therapy Efficiency

Wednesday, November 11, 2020

Risk of AAV Mobilization in Gene Therapy

Monday, November 9, 2020

Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair

Thursday, October 8, 2020

Treating Cystic Fibrosis with mRNA Therapy or CRISPR

Friday, September 18, 2020

Gene Therapy Corrects the Cardiac Effects of Friedreich’s Ataxia

Wednesday, September 2, 2020

Toxicity of Dorsal Root Ganglia Is Widely Associated with CNS AAV Gene Therapy

Thursday, August 13, 2020

Engineered Capsids for Efficient Gene Delivery to the Eye

Monday, August 10, 2020

Gene Therapy Targets Inner Retina to Combat Blindness

Thursday, March 26, 2020

Benefiting from the National Gene Vector Biorepository

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.